Phil Skolnick, Chief Scientific Officer at OPIANT PHARMACEUTICALS, INC. (OPNT), sold 369 shares at $20.20 ($7K) on 2023-01-09, disclosed to the SEC on 2023-01-09.
Seasonal sale ($7k) by Chief Scientific Officer — this insider has traded OPNT in January in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| OPNT | SELL | 2022-07-15 | $7K | — | Filing → |
| OPNT | SELL | 2022-01-27 | $40K | — | Filing → |
| OPNT | SELL | 2022-01-12 | $12K | — | Filing → |